@article{0859ae1c6b604b2794f8fd3daf20cb8d,
title = "Cost-Effectiveness of perioperative Vaginally Administered estrogen in postmenopausal women undergoing prolapse surgery (EVA trial): study protocol for a multicenter double-blind randomized placebo-controlled trial",
keywords = "Pelvic organ prolapse, Vaginal estrogen therapy, Postmenopausal, Wound healing, Pelvic reconstructive surgery, Recurrence, Cost-effectiveness, PELVIC ORGAN PROLAPSE, LOCAL ESTROGEN, LIFETIME RISK, ESTRADIOL, QUESTIONNAIRE, VALIDATION, RECURRENCE, OUTCOMES, SUPPORT, ATROPHY",
author = "E.V. Vodegel and S.E. Zwolsman and A. Vollebregt and R.G. Duijnhoven and J.E. Bosmans and L. Speksnijder and E.J. Roos and W. Spaans and F. Gerards and A. Adriaanse and F. Vernooij and A.L. Milani and M. Sikkema and M. Weemhoff and M. Mous and A. Damoiseaux and {van Dongen}, H. and {v d Ploeg}, M. and J. Veen and {van de Pol}, G. and B. Broekman and P. Steures and F. Tjin-Asjoe and {van der Stege}, J. and R. Mouw and {van der Vaart}, C.H. and J.P.W.R. Roovers",
year = "2021",
month = dec,
day = "31",
doi = "10.1186/s12905-021-01587-9",
language = "English",
volume = "21",
journal = "BMC Women's Health",
issn = "1472-6874",
publisher = "BioMed Central Ltd",
number = "1",
}